Franklin DynaTech Fund Q4 2025 Commentary

Franklin Templeton4.63K FollowersFollow5ShareSavePlay(10min)CommentsSummaryFranklin DynaTech Fund (Advisor Class without sales charges) underperformed the Russell 1000 Growth Index as five out of 11 sectors detracted.Individual stock performance varied with AI infrastructure plays like Oracle facing execution challenges and established leaders like Apple navigating leadership transitions.Biotechnology holdings benefited from stock selection and collectively rose more than 20%, led by key overweight contributor Natera. Genetic testing company Guardant Health also rallied. Love Employee/iStock via Getty Images Key Takeaways Markets: Global equities made further gains in the fourth quarter of 2025 (4Q25), rounding off a year of strong returns. Despite some mixed economic signals and investor concerns about the stretched valuations of many technology-related This article was written byFranklin Templeton4.63K FollowersFollowFranklin Resources, Inc. [NYSE:BEN] is a global investment management organization with subsidiaries operating as Franklin Templeton and serving clients in over 150 countries. Franklin Templeton’s mission is to help clients achieve better outcomes through investment management expertise, wealth management and technology solutions. Through its specialist investment managers, the company offers specialization on a global scale, bringing extensive capabilities in fixed income, equity, alternatives and multi-asset solutions. With more than 1,300 investment professionals, and offices in major financial markets around the world, the California-based company has over 75 years of investment experience and over $1.4 trillion in assets under management as of June 30, 2023. For more information, please visit franklintempleton.com and follow us on LinkedIn, Twitter and Facebook.